Edition:
United States

MediciNova Inc (MNOV.OQ)

MNOV.OQ on NASDAQ Stock Exchange Global Market

6.35USD
23 Oct 2017
Change (% chg)

$0.21 (+3.42%)
Prev Close
$6.14
Open
$6.23
Day's High
$6.43
Day's Low
$6.23
Volume
16,782
Avg. Vol
24,125
52-wk High
$7.77
52-wk Low
$4.40

Chart for

About

Medicinova, Inc. is a biopharmaceutical company. The Company focuses on acquiring and developing small molecule therapeutics for the treatment of diseases with unmet medical needs and a commercial focus on the United States market. Its pipeline includes MN-166 (ibudilast), MN-001 (tipelukast), MN-221 (bedoradrine) and MN-029... (more)

Overall

Beta: 0.23
Market Cap(Mil.): ¥24,620.59
Shares Outstanding(Mil.): 35.35
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 89.38 16.52
EPS (TTM): -- -- --
ROI: -- 2.39 11.32
ROE: -- 3.35 15.18

BRIEF-Medicinova Inc files for potential mixed ‍​shelf of up to $200 million

* Medicinova Inc files for potential mixed ‍​shelf of up to $200 million - SEC filing Source text: [http://bit.ly/2fgDO2R] Further company coverage:

Sep 22 2017

BRIEF-MediciNova completes enrollment in the phase 2 trial of MN-166 in methamphetamine dependence

* MediciNova announces the completion of enrollment in the phase 2 clinical trial of MN-166 (ibudilast) in methamphetamine dependence

Sep 19 2017

BRIEF- MediciNova completes off-floor distribution

* Says it completes the off-floor distribution of shares on June 13

Jun 12 2017

BRIEF- MediciNova to offer off-floor distribution of shares

* Says it will offer an off-floor distribution of 800,000 shares of its stock at the price of 602 yen per share, on the Tokyo Stock Exchange on June 13

Jun 12 2017

BRIEF-MediciNova to offer off-floor distribution of shares

* Says it will offer an off-floor distribution of 800,000 shares on Tokyo Stock Exchange, from June 13 to June 15

Jun 05 2017

Earnings vs. Estimates